Rankings / Comparisons

Ashwagandha (Withania somnifera) vs Rhodiola rosea

Two adaptogens with overlapping marketing claims and very different evidence bases.

Bottom line

On the composite score, Rhodiola rosea (B+, 7.1/10) edges out Ashwagandha (Withania somnifera) (B-, 6.3/10) — but the right pick depends on the specific outcome you're optimising for.

Ashwagandha (Withania somnifera)

B- 6.3/10

aka KSM-66, Sensoril

Evidence
Moderate (stress/anxiety; small testosterone effect in men per Lopresti 2019; modest muscle/strength gains) (6/10)
Benefit
Moderate (5/10)
Risk
Low-Med (hepatotoxicity — emerging case reports since 2020; thyroid hormone elevation — caution in hyperthyroidism or on levothyroxine; sedating; theoretical concerns with autoimmune conditions) (7/10 safety)
Legality
OTC
Dose
300-600 mg/day standardized extract (KSM-66 or Sensoril most studied)
Class
Herbal
Last reviewed
Jun 8, 2026

Read Off Label grades Ashwagandha (Withania somnifera) as B- (6.3/10) based on moderate evidence, moderate benefit magnitude, and a low-med-risk safety profile.

Most-popular adaptogen in the West, with better clinical trial base than most (Chandrasekhar 2012, Lopresti 2019, 2021).

Typical use: 300-600 mg/day standardized extract (KSM-66 or Sensoril most studied) — OTC.

What it is

Most-popular adaptogen in the West, with better clinical trial base than most (Chandrasekhar 2012, Lopresti 2019, 2021). Iceland and Denmark added warnings 2023 after multiple case reports of DILI (drug-induced liver injury). Take time-separated from thyroid hormone (can affect absorption). Cycle if using chronically. Emerging 2025-2026 case reports describe HPA-axis suppression and withdrawal-type symptoms with chronic use — too sparse to establish incidence but reinforcing the case for cycling. A 2026 meta-analysis (20 RCTs, n=1,249) reported significant cognitive gains - memory SMD 0.52, attention/processing speed SMD 0.29 - plus muscle-strength, testosterone, and body-composition improvements (GRADE-assessed; Front Pharmacol 2026).

Mechanism

Ayurvedic 'Indian ginseng'; withanolides (withaferin A, withanolide D); HPA axis modulation — reduces cortisol response to stress; GABAergic; thyroid-stimulating effects

Full Ashwagandha (Withania somnifera) review →

Rhodiola rosea

B+ 7.1/10

Evidence
Moderate (fatigue, burnout, mild depression, exercise recovery) (6/10)
Benefit
Med (5/10)
Risk
Low (generally well-tolerated) (9/10 safety)
Legality
OTC
Dose
200-600 mg/day standardized extract (3% rosavin, 1% salidroside)
Class
Herbal
Last reviewed
Jun 8, 2026

Read Off Label grades Rhodiola rosea as B+ (7.1/10) based on moderate evidence, med benefit magnitude, and a low-risk safety profile.

Best-studied adaptogen outside of ashwagandha.

Typical use: 200-600 mg/day standardized extract (3% rosavin, 1% salidroside) — OTC.

What it is

Best-studied adaptogen outside of ashwagandha. Effects generally described as subtle — reduced fatigue and stress tolerance rather than acute stimulation. Most notable in fatigue/burnout states.

Mechanism

Arctic adaptogen; rosavins and salidrosides; modulates HPA axis and monoamine metabolism; reduces cortisol response to stress; mitochondrial support

Full Rhodiola rosea review →

Common questions

Which is better, Ashwagandha (Withania somnifera) or Rhodiola rosea?
On the composite score, Rhodiola rosea (B+, 7.1/10) edges out Ashwagandha (Withania somnifera) (B-, 6.3/10) — but the right pick depends on the specific outcome you're optimising for.
What's the difference between Ashwagandha (Withania somnifera) and Rhodiola rosea?
Two adaptogens with overlapping marketing claims and very different evidence bases.
Can you take Ashwagandha (Withania somnifera) and Rhodiola rosea together?
Read Off Label doesn't make stack recommendations — see the disclaimer. Both compounds have individual mechanism, dose, and risk profiles documented on their respective pages; combining them is a clinical question that depends on the goal, indication, and other context.

This is an independent synthesis of published research by a non-clinician. Comparison-page verdicts use the composite Read Off Label score as a tiebreaker, but the right pick for any given person depends on indication, context, and clinician input. See the full disclaimer and methodology.